Scotland Pauses Gender Medications for Minors
The change followed a sweeping review by England’s National Health Service that found “remarkably weak” evidence for youth gender treatments.
By Azeen Ghorayshi
The change followed a sweeping review by England’s National Health Service that found “remarkably weak” evidence for youth gender treatments.
By Azeen Ghorayshi
Have your out-of-network insurance bills skyrocketed? Chris Hamby, an investigative reporter for The Times, may have an explanation.
By Josh Ocampo
Prescriptions for social activities, exercise and the arts — first popularized in Britain — are coming to America. But some experts say the U.S. health care system may get in the way.
By Christina Caron
In the year after a pandemic-era policy preserving Medicaid coverage lapsed, more than 20 million people were dropped from the program at some point.
By Noah Weiland
The lawsuit, brought by the Transgender American Veterans Association, said the Veteran Affairs department’s decision not to offer the procedures was discriminatory.
By Aishvarya Kavi
We want to hear from pet owners about their experiences taking their animals to the vet, and how they paid for their animals’ care.
By Katie Thomas
If health care is interpreted in the truest sense of caring for people’s health, it must extend well beyond the boundaries of hospitals and clinics.
By Lindsay Ryan
Five European countries have recently restricted hormone treatments for adolescents with gender distress. They have not banned the care, unlike many U.S. states.
By Azeen Ghorayshi
A nonprofit group called R.I.P. Medical Debt has relieved Americans of $11 billion in hospital bills. But that did not improve their mental health or their credit scores, a study found.
By Sarah Kliff
A little-known data firm helps health insurers earn more when less of an out-of-network claim gets paid. Patients can be on the hook for the difference.
By Chris Hamby, Claire Hogan and James Surdam
Advertisement
Advertisement